Hypothetically, harmonizing the U.S. definition of a cosmetic with that in the European Union could result in fewer FDA warning letters and potentially benefit consumers, but increased leeway for product claims likely would come at a cost to small businesses.
Recent warnings issued to cosmetics manufacturers in the states largely have centered on benefit claims that define recipients’ products as...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?